Online citations, reference lists, and bibliographies.
← Back to Search

Potential Of Nanomaterials As Movers And Packers For Drug Molecules

I. P. Kaur, Mandeep Singh, Monika Yadav, S. K. Sandhu, Parneet Kaur Deol, Gaurav Sharma
Published 2014 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
As the development of nanotechnology has extended to the world of biomolecules, a revolution has occurred in the design and assembly of nanomaterials for drug delivery with a significant potential to impact drug efficacy and patient outcomes. Currently a number of nanomaterials are under investigation for their suitability as sustained, controlled and targeted drug carriers. Leading edge of the rapidly developing nanosciences is the development and assessment of these nanomaterials, with specific physicochemical properties different from their larger/ bulk counterparts, as vehicles for transport of small and large drug molecules. The characteristics such as size, shape, chemical composition, surface structure and charge, aggregation and agglomeration, and solubility, can greatly influence interactions of these nanostructured systems or carriers with biomembranes and cells. The selectivity and reactivity achieved due to the very small size assigns these systems with a wide spectrum of applications. In this review, nanomaterials are considered in terms of the physical attributes or pharmaceutical effects allocated by them to the all-inclusive carrier or vehicle system (s). However we will limit our discussion to lipidic and polymeric nanomaterials, the two most commonly promoted, and safe nanosystems for delivery of both, the chemical or small molecular entities (SME) and the macromolecules including genes and siRNA.Contents of Paper
This paper references
10.1002/JPS.20216
Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
Goldie Kaul (2005)
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
E. Zimmermann (2005)
10.1088/0957-4484/21/2/025101
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.
Jie Shen (2010)
10.1016/j.ijpharm.2011.12.009
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Ming-Jun Tsai (2012)
10.1016/J.FOODHYD.2012.11.006
The effect of polymer–surfactant emulsifying agent on the formation and stability of α-lipoic acid loaded nanostructured lipid carriers (NLC)
K. Zheng (2013)
Composition of solid lipid nanoparticles for the long-term conservation of fruits, vegetables, seeds, cereals and/or fresh foodstuffs using a coating EP2698066 A2
G D Quintanar (2014)
In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres.
M. S. Espuelas (2002)
10.1007/s11051-012-0902-9
Highly antioxidant carotene-lipid nanocarriers: synthesis and antibacterial activity
I. Lăcătuşu (2012)
10.1201/b19309
Encyclopedia of Pharmaceutical Technology
J. Swarbrick (2006)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.2147/IJN.S15881
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
S. Eskandari (2011)
10.1016/j.ijpharm.2014.04.061
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles.
A. Leonardi (2014)
10.1016/j.nano.2010.06.003
Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
Soheila Kheradmandnia (2010)
10.1016/j.jconrel.2014.06.004
Solid lipid excipients - matrix agents for sustained drug delivery.
Y. Rosiaux (2014)
10.1021/bm101584c
Formation and properties of chitosan-cellulose nanocrystal polyelectrolyte-macroion complexes for drug delivery applications.
Hezhong Wang (2011)
Nanoencapsulation I
C. P. Reis (2006)
10.1016/j.jconrel.2013.09.019
Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Ahmed O Elzoghby (2013)
10.1016/j.ejpb.2008.05.008
Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Jia-You Fang (2008)
10.1039/c2nr32145a
Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
Meihua Yu (2013)
10.7150/IJBS.5.153
Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa
S. Tin (2009)
10.1016/J.ADDR.2007.04.004
Stability of lipid excipients in solid lipid nanoparticles.
A. Radomska-Soukharev (2007)
10.1208/s12249-013-0034-2
Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
Thiagarajan Madheswaran (2013)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1515/9783111697888-007
E
Adam S. Opalski (1824)
10.1186/1556-276X-8-161
Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy
Y. Zheng (2013)
10.1016/j.ijpharm.2010.04.005
The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
F. Li (2010)
Nanomaterials for drug delivery: Potential benefits and risks
B. E. Barry (2006)
10.1016/J.COLSURFA.2009.11.006
Optimization of nanostructured lipid carriers for lutein delivery
C. Liu (2010)
10.1166/JCSB.2012.1010
Encapsulation and Release Behavior from Lipid Nanoparticles: Model Study with Nile Red Fluorophore
Thomas Delmas (2012)
10.1111/J.1467-2494.2004.00252_4.X
Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations.
E. Souto (2004)
10.1016/j.ejpb.2013.08.009
Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study.
M. Schoenitz (2014)
10.1080/03639040500215750
Interest of Multifunctional Lipid Excipients: Case of Gelucire® 44/14
O. Chambin (2005)
10.1016/j.ijpharm.2008.01.008
Solid lipid nanoparticles for pulmonary delivery of insulin.
J. Liu (2008)
10.1016/j.colsurfb.2011.07.060
Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
Y. Kuo (2011)
10.1023/A:1016486910719
Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery
Goldie Kaul (2004)
10.1016/S1995-7645(10)60010-7
Surface modified solid lipid microparticles based on homolipids and Softisan® 142: preliminary characterization
Po Nnamani (2010)
10.3109/10837450.2013.763261
All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier
Ponwanit Charoenputtakhun (2014)
10.1016/J.ADDR.2007.04.010
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
P. Chattopadhyay (2007)
10.3109/10837450.2013.778872
Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam
R. Khalil (2014)
10.1016/j.ejpb.2010.05.001
Preservation of nanostructured lipid carriers (NLC).
W. Obeidat (2010)
10.1038/mt.2013.245
TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
S. Lee (2014)
Preparation of solid lipid nanoparticles of rifampicin to improve bioavailability and limiting drug interaction with isoniazid, India Patent
I P Kaur (2013)
10.1016/S0168-3659(02)00492-3
Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol.
M. Sheu (2003)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.1016/j.colsurfb.2010.02.003
Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy ((1)H NMR).
Hazem Ali (2010)
10.1016/j.jconrel.2007.12.018
Potential of solid lipid nanoparticles in brain targeting.
I. P. Kaur (2008)
10.1515/9783111413426-013
L
Il Liceo (1824)
Overview of food emulsifiers, Food emulsifiers and their applications
G L Hasenhuettl (2008)
10.1016/J.COLSURFA.2007.07.035
Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity
A. Attama (2008)
Solid lipid nanoparticles comprising internal Compritol 888 ATO
Y. C. Kuo (2011)
10.1208/s12249-009-9197-2
Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
G. Abdelbary (2009)
10.1016/S0168-3659(99)00073-5
Preparation and characterization of protein C-loaded PLA nanoparticles.
M. Zambaux (1999)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
S.E.Mercado, Composition of solid lipid nanoparticles for the long-term conservation of fruits, vegetables, seeds, cereals and/or fresh foodstuffs using a coating EP2698066
G. D. Quintanar (2014)
Composition of solid lipid nanoparticles for the long - term conservation of fruits , vegetables ,
Z. M. Zambrano Quintanar (2014)
10.1007/978-0-387-75284-6_1
Overview of Food Emulsifiers
Gerard L. Hasenhuettl (2008)
10.1088/0957-4484/25/10/105101
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
S. Das (2014)
10.1016/J.CARBPOL.2012.01.051
Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
J. Varshosaz (2012)
10.18433/J3JC7C
Chitosan mediated targeted drug delivery system: a review.
M. P. Patel (2010)
Preparation of solid lipid nanoparticles of rifampicin to improve bioavailability and limiting drug interaction with isoniazid
I. P. Kaur (2013)
10.1016/J.PROGPOLYMSCI.2012.04.004
Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
Piyasi Mukhopadhyay (2012)
10.1016/J.TIFS.2011.08.003
Nanoencapsulation of food ingredients using lipid based delivery systems
Milad Fathi (2012)
10.1002/JPS.2600670320
Sustained release from inert wax matrixes I: drug-wax combinations.
H. Schroeder (1978)
10.1016/J.IJPHARM.2012.03.007
Corrigendum to “Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting” [Int. J. Pharm. 423 (2012) 461–470]
Ming-Jun Tsai (2012)
10.1016/S0960-8524(03)00002-6
Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens.
Y. Chung (2003)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1016/S0378-5173(99)00153-2
Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
J. Matsumoto (1999)
10.2147/IJN.S33682
Development of terbinafine solid lipid nanoparticles as a topical delivery system
Y. Chen (2012)
10.1016/j.colsurfb.2009.09.033
Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
S. Doktorovová (2010)
10.1248/CPB.58.1423
Chitosan nanoparticles: a promising system in novel drug delivery.
K. Nagpal (2010)
10.1021/mp400269z
Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
J. Chen (2014)
10.1021/nl2035354
Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.
Warefta Hasan (2012)
10.1080/1061186021000060738
In Vitro Antileishmanial Activity of Amphotericin B Loaded in Poly(ε-Caprolactone) Nanospheres
M. S. Espuelas (2002)
Polyethylene glycols (PEGs) and the pharmaceutical industry
T. Henning (2001)
10.1016/j.addr.2006.09.009
Multifunctional nanocarriers.
V. Torchilin (2006)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1016/j.colsurfb.2012.08.058
Solid lipid nanoparticles as delivery systems for Gambogenic acid.
X. Huang (2013)
10.3109/02652048.2012.668960
Enhanced payload and photo-protection for pesticides using nanostructured lipid carriers with corn oil as liquid lipid
H. M. Nguyen (2012)
10.1016/j.colsurfb.2013.06.032
Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Jiabei Sun (2013)
10.21608/bfsa.2010.64767
FORMULATION AND CHARACTERIZATION OF GELUCIRE PELLETS FOR SUSTAINED RELEASE OF IBUPROFEN
G. Fetih (2010)
10.1016/J.EJPB.2004.04.006
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting.
Leila Nobs (2004)
Food emulsions: principles
D. J. McClements (2005)
10.1016/J.COLSURFA.2007.08.005
Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers
F. Han (2008)
10.1016/j.ejps.2011.04.005
Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
Tiecheng Zhang (2011)
10.1021/nl300395q
Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.
F. M. Mickler (2012)
10.3844/AJPTSP.2008.219.224
Tamoxifen Drug Loading Solid Lipid Nanoparticles Prepared by Hot High Pressure Homogenization Techniques
Nagi A. Alhaj (2008)
10.3109/10837450903013568
Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design
J. Varshosaz (2010)
10.1016/j.ijpharm.2012.03.042
Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Guo Chen-yu (2012)
10.1016/j.ijpharm.2011.05.008
Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Khalil Mitri (2011)
ROLE OF BIODEGRADABLE POLYMERS IN DRUG DELIVERY
J. Joshi (2012)
10.1016/J.COLSURFB.2005.08.005
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
F. Hu (2005)
10.1158/1078-0432.CCR-04-1443
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Z. Lu (2004)
10.1016/S0924-2244(99)00042-4
Food emulsions: principles, practice, and techniques
P. Walstra (1999)
10.1016/J.EJPB.2006.09.004
Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
K. Derakhshandeh (2007)
10.3923/PJBS.2012.141.146
Characterization and stability of nanostructured lipid carriers as drug delivery system.
R. Abbasalipourkabir (2012)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.1016/j.colsurfb.2010.12.014
Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids.
Shuyu Xie (2011)
10.4103/0250-474X.58188
Effect of Processing and Sintering on Controlled Release Wax Matrix Tablets of Ketorolac Tromethamine
M. Rao (2009)
10.1063/1.4810151
Effect of surfactant on temperature stability of solid lipid nanoparticles studied by dynamic light scattering
S. Kumar (2013)
Physicochemical Process for Wastewater Control
W. B. Weber (1992)
Acute toxicity study of tilmicosin - loaded hydrogenated castor oil - solid lipid nanoparticles , Part
F. Wang
10.1016/J.CARRES.2004.09.007
Preparation and antibacterial activity of chitosan nanoparticles.
Lifeng Qi (2004)
10.1208/s12249-011-9733-8
Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug
Akhayacatra Chinsriwongkul (2011)
10.1080/13602360500115095
Formulation
J. Peponis (2005)
10.1007/s11095-014-1337-z
Solid Lipid Particles for Oral Delivery of Peptide and Protein Drugs II – The Digestion of Trilaurin Protects Desmopressin from Proteolytic Degradation
P. C. Christophersen (2014)
10.1002/ps.3268
Photoprotection for deltamethrin using chitosan-coated beeswax solid lipid nanoparticles.
H. M. Nguyen (2012)
Encapsulation of 9-nitrocamptothecin
K. Derakhshandeh (2007)
10.1208/s12249-014-0159-y
Optimization of Dexamethasone Mixed Nanomicellar Formulation
K. Cholkar (2014)
10.1007/s11671-009-9345-3
Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA
W. Zou (2009)
10.5246/JCPS.2011.04.049
Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery
Peiran Zhang (2011)
10.1021/BM034130M
Chitosan as antimicrobial agent: applications and mode of action.
E. Rabea (2003)
10.1155/2013/863951
Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges
A. Babu (2013)
10.1186/1743-8977-8-33
Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles
Shuyu Xie (2011)
10.1016/J.POLYMER.2006.05.011
Thermosensitive poly(N-isopropylacrylamide)-b-poly(ε-caprolactone) nanoparticles for efficient drug delivery system
C. Choi (2006)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1186/1556-276X-8-197
Development of dextran nanoparticles for stabilizing delicate proteins
F. Wu (2013)
10.1007/S11746-010-1553-6
Properties and Stability of Solid Lipid Particle Dispersions Based on Canola Stearin and Poloxamer 188
C. C. Trujillo (2010)
Autoclavable nanovesicular composition 700/Del/2014
I. P. Kaur (2014)
10.1016/j.colsurfb.2010.11.037
Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Y. Kuo (2011)
10.1016/j.ejpb.2009.12.008
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
C. Chen (2010)
10.2217/nnm.10.42
Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
Shuyu Xie (2010)
10.1016/j.ijpharm.2011.07.040
Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
J. Pardeike (2011)
10.1007/s11947-012-0845-2
Hesperetin-Loaded Solid Lipid Nanoparticles and Nanostructure Lipid Carriers for Food Fortification: Preparation, Characterization, and Modeling
Milad Fathi (2012)
10.1080/02652040500162436
SLN and NLC for topical delivery of ketoconazole
E. Souto (2005)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1089/rej.2011.1193
Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements.
V. Kakkar (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar